CCRM’s Board of Directors represents extensive experience in company creation, international academic excellence and seasoned leaders sourced from the regenerative medicine industry.
- Gregory Bonfiglio, Proteus Venture Partners, USA
- Allen Eaves, STEMCELL Technologies Inc., Canada
- Rafi Hofstein, MaRS Innovation, Canada
- Peter Lewis, University of Toronto, Canada
- Michael May, Centre for Commercialization of Regenerative Medicine, Canada
- Geoff MacKay, Organogenesis, USA
- Stephen Minger, GE Healthcare, UK
- Gail Naughton, Histogen Inc., USA
- Christopher Paige, University Health Network, Canada
- David Smith, Lonza, USA
- Susan L. Solomon, New York Stem Cell Foundation (NYSCF).
- Duncan Stewart, Ottawa Hospital Research Institute, Canada
- Peter Zandstra, Centre for Commercialization of Regenerative Medicine, Canada
Past Board Members
Thank you to those who have contributed their valuable time, insight and expertise to CCRM's Board of Directors during their committed term.